Literature DB >> 26143300

High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participants.

Joshua A Barocas1, Lisa Baker2, Shawnika J Hull3, Scott Stokes4, Ryan P Westergaard5.   

Abstract

BACKGROUND: Incarceration is common among people who inject drugs. Prior research has shown that incarceration is a marker of elevated risk for opioid overdose, suggesting that the criminal justice system may be an important, under-utilized venue for implementing overdose prevention strategies. To better understand the feasibility and acceptability of such strategies, we evaluated the utilization of naloxone-based overdose prevention training among people who inject drugs with and without a history of incarceration.
METHODS: We surveyed clients who utilize a multi-site syringe exchange program (SEP) in 2 cities in the Midwestern United States. Participants completed an 88-item, computerized survey assessing history of incarceration, consequences associated with injection, injecting practices, and uptake of harm reduction strategies.
RESULTS: Among 543 respondents who injected drugs in the prior 30 days, 243 (43%) reported prior incarceration. Comparing those with and without a history of incarceration, there were no significant differences with respect to age, gender, or race. Those who observed an overdose, experienced overdose, and received training to administer or have administered naloxone were more likely to report incarceration. Overall, 69% of previously incarcerated clients had been trained to administer naloxone.
CONCLUSION: People who inject drugs with a history of incarceration appear to have a higher risk of opioid overdose than those never incarcerated, and are more willing to utilize naloxone as an overdose prevention strategy. Naloxone training and distribution is an important component of comprehensive prevention services for persons with opioid use disorders. Expansion of services for persons leaving correctional facilities should be considered.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Correctional facilities; Overdose; People who inject drugs; Risky health behaviors; Take-home naloxone

Mesh:

Substances:

Year:  2015        PMID: 26143300      PMCID: PMC4807604          DOI: 10.1016/j.drugalcdep.2015.06.023

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  13 in total

1.  Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study.

Authors:  John Strang; Jim McCambridge; David Best; Tracy Beswick; Jenny Bearn; Sian Rees; Michael Gossop
Journal:  BMJ       Date:  2003-05-03

2.  Male drugs-related deaths in the fortnight after release from prison: Scotland, 1996-99.

Authors:  Sheila M Bird; Sharon J Hutchinson
Journal:  Addiction       Date:  2003-02       Impact factor: 6.526

3.  Attitudes and practices regarding the use of methadone in US state and federal prisons.

Authors:  Josiah D Rich; Amy E Boutwell; David C Shield; R Garrett Key; Michelle McKenzie; Jennifer G Clarke; Peter D Friedmann
Journal:  J Urban Health       Date:  2005-05-25       Impact factor: 3.671

4.  Release from prison--a high risk of death for former inmates.

Authors:  Ingrid A Binswanger; Marc F Stern; Richard A Deyo; Patrick J Heagerty; Allen Cheadle; Joann G Elmore; Thomas D Koepsell
Journal:  N Engl J Med       Date:  2007-01-11       Impact factor: 91.245

Review 5.  Drug-related death following release from prison: a brief review of the literature with recommendations for practice.

Authors:  D Leach; P Oliver
Journal:  Curr Drug Abuse Rev       Date:  2011-12

6.  Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability.

Authors:  J Strang; B Powis; D Best; L Vingoe; P Griffiths; C Taylor; S Welch; M Gossop
Journal:  Addiction       Date:  1999-02       Impact factor: 6.526

7.  Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study.

Authors:  Karen H Seal; Robert Thawley; Lauren Gee; Joshua Bamberger; Alex H Kral; Dan Ciccarone; Moher Downing; Brian R Edlin
Journal:  J Urban Health       Date:  2005-05-04       Impact factor: 3.671

8.  Preventing death among the recently incarcerated: an argument for naloxone prescription before release.

Authors:  Sarah E Wakeman; Sarah E Bowman; Michelle McKenzie; Alexandra Jeronimo; Josiah D Rich
Journal:  J Addict Dis       Date:  2009

9.  Evaluation of the Staying Alive programme: training injection drug users to properly administer naloxone and save lives.

Authors:  Karin E Tobin; Susan G Sherman; Peter Beilenson; Christopher Welsh; Carl A Latkin
Journal:  Int J Drug Policy       Date:  2008-04-22

Review 10.  Meta-analysis of drug-related deaths soon after release from prison.

Authors:  Elizabeth L C Merrall; Azar Kariminia; Ingrid A Binswanger; Michael S Hobbs; Michael Farrell; John Marsden; Sharon J Hutchinson; Sheila M Bird
Journal:  Addiction       Date:  2010-06-23       Impact factor: 6.526

View more
  8 in total

Review 1.  The relationship between incarceration history and overdose in North America: A scoping review of the evidence.

Authors:  Sasha Mital; Jessica Wolff; Jennifer J Carroll
Journal:  Drug Alcohol Depend       Date:  2020-05-24       Impact factor: 4.492

2.  Awareness, Possession, and Use of Take-Home Naloxone Among Illicit Drug Users, Vancouver, British Columbia, 2014-2015.

Authors:  Seonaid Nolan; Jane Buxton; Sabina Dobrer; Huiru Dong; Kanna Hayashi; M J Milloy; Thomas Kerr; Julio Montaner; Evan Wood
Journal:  Public Health Rep       Date:  2017-07-27       Impact factor: 2.792

Review 3.  Factors associated with opioid-involved overdose among previously incarcerated people in the U.S.: A community engaged narrative review.

Authors:  Juliet M Flam-Ross; Josh Lown; Prasad Patil; Laura F White; Jianing Wang; Ashley Perry; Dennis Bailer; Michelle McKenzie; Anthony Thigpen; Roxxanne Newman; Meko Lincoln; Tyrone Mckinney; Dana Bernson; Joshua A Barocas
Journal:  Int J Drug Policy       Date:  2021-12-09

4.  Examining risk behavior and syringe coverage among people who inject drugs accessing a syringe services program: A latent class analysis.

Authors:  Tyler S Bartholomew; Hansel E Tookes; Corinne Bullock; Jason Onugha; David W Forrest; Daniel J Feaster
Journal:  Int J Drug Policy       Date:  2020-03-05

5.  Justice involvement patterns, overdose experiences, and naloxone knowledge among men and women in criminal justice diversion addiction treatment.

Authors:  Rachel E Gicquelais; Briana Mezuk; Betsy Foxman; Laura Thomas; Amy S B Bohnert
Journal:  Harm Reduct J       Date:  2019-07-16

6.  A Study on the Efficacy of a Naloxone Training Program.

Authors:  Gillian A Beauchamp; Hoonani M Cuadrado; Seth Campbell; Bennie B Eliason; Chase L Jones; Aaron T Fedor; Lauren Grantz; Paige Roth; Marna Rayl Greenberg
Journal:  Cureus       Date:  2021-11-23

7.  Associations Between Copays, Coverage Limits for Naloxone, and Prescribing in Medicaid.

Authors:  John C Messinger; Aaron S Kesselheim; Seanna M Vine; Michael A Fischer; Rachel E Barenie
Journal:  Subst Abuse       Date:  2022-09-29

8.  A scoping review of factors that influence opioid overdose prevention for justice-involved populations.

Authors:  Christine E Grella; Erika Ostlie; Christy K Scott; Michael L Dennis; John Carnevale; Dennis P Watson
Journal:  Subst Abuse Treat Prev Policy       Date:  2021-02-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.